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A B S T R A C T
Driven by the raising ethical concerns surrounding animal experimentation, there is a growing interest for non-
animal methods, in vitro or in silico technologies that can be used to reduce, reﬁne, and replace animal ex-
perimentation. In addition, animal experimentation is being critically revised in regard to its ability to predict
clinical outcomes. In this manuscript we describe an initial exploration where a set of in vivo imaging based
subject-speciﬁc technologies originally developed to predict the risk of femoral strength and hip fracture in
osteoporotic patients, were adapted to assess the eﬃcacy of bone drugs pre-clinically on mice. The CT2S
technology we developed generates subject-speciﬁc models based on Computed Tomography that can separate
fractured and non-fractured patients with an accuracy of 82%. When used in mouse experiments the use of in
vivo imaging and modelling was found to improve the reproducibility of Bone Mineral Content measurements to
a point where up to 63% less mice would be required to achieve the same statistical power of a conventional
cross-sectional study. We also speculate about a possible approach where animal-speciﬁc and patient-speciﬁc
models could be used to better translate the observation made on animal models into predictions of response in
humans.
1. Introduction
There is a growing interest for non-animal methods, in vitro or in silico
technologies that can be used to reduce, reﬁne, and replace animal
experimentation (see for example this review relative to vision research
(Combes and Shah, 2016); the primary motivation is the raise in our
societies of ethical concerns with animal experimentation.
But there is another problem that drives the critical revision of
animal experimentation: According to a recent BIO report1, based on a
database of nearly 10,000 regulatory phase transitions, the Likelihood
of Approval from phase I (after the compound has successfully passed
the pre-clinical assessment, mostly based on animal experimentation)
ranges between 26.1% in haematology to 5.1% in oncology, with an
average across all indications of 9.6%. That mean that in the best-case
scenario animal models are able to spot all safety and eﬃcacy issues
associated with a new compound only one time out of four.
In parallel there is a growing enthusiasm around the use of subject-
speciﬁc computer modelling and simulation to support the clinical
decision. Developed in Europe under the ﬂag name of Virtual
Physiological Human (VPH), and elsewhere with that of Physiome
Project, these technologies are capable of accurately predict the disease
progression and the eﬀect of diﬀerent treatments in individual patients,
for a variety of conditions (Viceconti and Hunter, 2016).
Computational methods have been used in the last few years to
investigate various aspects on skeletal ageing (Lambers et al., 2015;
Patel et al., 2014; Razi et al., 2015a,b; Yang et al., 2017). In this
manuscript we describe an initial exploration where a set of VPH
technologies, originally developed to predict the risk of femoral
strength and hip fracture in osteoporotic patients, were adapted to as-
sess the eﬃcacy of bone drugs pre-clinically on mice. We also propose
an approach where animal-speciﬁc and patient-speciﬁc models could be
used to better translate the observation made on animal models into
predictions of response in humans.
2. CT2S: predicting the individual risk of hip fracture in
osteoporotic patients
Osteoporosis is a silent disease, in the sense that the patient has no
symptoms, until a minor trauma, with impact energy much lower than
what is normally required, produces a bone fracture (hereinafter called
fragility fracture). The whole skeleton is aﬀected, but the most common
fractures are at the wrist, the ankle, the spine, and at the hip. The latter,
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because of the severity of the consequences, is of particular clinical
relevance.
Pharmacological treatments exist that slow down the progression of
the disease, reducing the incidence of fragility fractures of 40% or
better (Sanderson et al., 2016). But because this is a long-term therapy,
with considerable associated costs, and some potential side eﬀects, it is
essential to recognise who are the patients with a suﬃciently high risk
of fragility fractures to justify such pharmacological treatment.
It is not trivial to deﬁne the accuracy with which a predictor iden-
tiﬁes the patients at higher risk. One possible approach is to build ar-
tiﬁcial cohorts where patients who experienced a fragility fracture be-
fore being treated, and then for each of them identify another patient
who did not had any fragility fracture yet, but match the fractured
patient in gender, age, weight, and height. One of such cohorts, here-
inafter referred as the Sheﬃeld Cohort, includes 50 postmenopausal
women with a fragility hip fracture and 50 control cases (no fractures),
pair-matched by gender, age, weight, and height (Yang et al., 2014).
With such cohorts it is possible to compare the accuracy of risk pre-
dictors in term of their ability to discriminate the fractured patients and
non-fractured ones; this will be referred to hereinafter as discrimination
accuracy.
The risk of experiencing a fragility hip fracture is strongly related to
the side-fall strength of the patient’s femur, intended as the force re-
quired to fracture the femoral bone, under loading conditions similar to
those observed during side-fall impact with the ﬂoor. Strength can be
measured only invasively; however, a number of methods use medical
imaging to acquire non-invasively information about shape and/or the
degree of mineralisation of the patient’s bone and use this information
to estimate the strength. The current clinical standard involves mea-
suring the areal Bone Mineral Density (aBMD) at the hip region using a
specialised medical imaging technology called Dual X-ray
Absorptiometry (DXA). Since 1985 (Basu et al., 1985), a number of
research groups have reﬁned the methods involved with an alternative
approach, where quantitative computed tomography (QCT) of the fe-
moral region is used to generate a subject-speciﬁc ﬁnite element model
(SSFE) of the patient’s bone, a computer model that is used to predict
the femoral strength.
In a recent meta-analysis, conducted over a set of studies run by ﬁve
diﬀerent groups and that involved over 400 cadaver femurs, we showed
that QCT-SSFE is more accurate (84–85%) than DXA-aBMD (77–81%)
in predicting femoral strength in side fall, as measured in cadaver fe-
murs (Viceconti et al., 2018). However, until recently, QCT-SSFE was
reported to be not signiﬁcantly more accurate than DXA-aBMD in
predicting the risk of hip fracture (Zysset et al., 2015), due to a number
of methodological issues. The CT2S technology developed in Sheﬃeld
has addressed most of these issues eﬀectively. The femoral geometry is
segmented from the CT images, and then automatically meshed with
parabolic 10-node tetrahedral elements using a modiﬁed version of the
advancing front method. The resulting mesh is projected back onto the
CT images, and the calibrated CT attenuation coeﬃcients are numeri-
cally averaged over the volume of each ﬁnite element, assuming tri-
linear interpolation between voxel values, in order to generate het-
erogenous material properties mapping. As human femurs exhibit a
clearly fragile failure under side fall loading, we use a maximum strain
failure criterion with diﬀerent limits for tension and compression. Over
the years the method was reﬁned through extensive methodological
research (Polgar et al., 2001; Taddei et al., 2004; Viceconti and Taddei,
2003; Viceconti et al., 1999a,b; Zannoni et al., 1998), subjected to
extensive veriﬁcation (Taddei et al., 2006; Viceconti et al., 2004), and
equally extensive validation against strain and strength measurements
on cadaver femurs (Grassi et al., 2012; Schileo et al., 2014, 2008a;
Schileo et al., 2008b, 2007). The method was further developed to be
used as a clinical predictor of the risk of fracture (Falcinelli et al., 2014;
Qasim et al., 2016); on the Sheﬃeld cohort the stratiﬁcation accuracy
of CT2S is 82%, while that of DXA-aBMD is 75% (Viceconti et al.,
2018).
3. DigiMouse: imaging & modelling technologies to quantify bone
adaptation to therapies
The generic term of “bone drugs” indicates a variety of pharma-
ceutical products (Alendronate, Risedronate, Ibandronate, Zoledronic
acid, Denosumab, Raloxifene, Teriparatide, Abaloparatide, etc.) which
through fairly diﬀerent mechanisms of actions slow down or reverse the
progressive loss of bone mass. The most common animal models used to
test the eﬃcacy of new bone drugs use wild-type (WT) female mice of
C57BL/6 or Balb-C strains, typically aged around 14 weeks, who all
receive an abdominal surgery; for half this involves the removal of the
ovaries (OVX), and for the other half only the sham surgery (SHAM).
Each of the two groups is subdivided in two sub-groups, one that is
injected with the drug being tested, the other with just the vehicle.
After a period of treatment, typically four weeks, all animals are sa-
criﬁced, one bone (typically the tibia or the femur) is harvested, and
two small portions of 2–3 cubic millimetres of bone tissue below the
proximal growth plate and in the mid-shaft are scanned with micro-
computed tomography (microCT) (Ruegsegger et al., 1996) in order to
evaluate the properties of the cancellous and cortical bone, respectively
(Bouxsein et al., 2010). From the obtained images 3D histomorpho-
metric measurements can be performed to describe the tissue density
and morphology. The most important parameter is called bone volume
fraction (BV/TV), which is the volume of bone that is mineralised in the
considered region of interest (ROI) over the total volume of the ROI.
The higher is the BV/TV of the treated animals compared to those non-
treated, the more eﬀective is considered the treatment. The high-re-
solution microCT images allow also measuring other important micro-
structural parameters as trabecular thickness (Tb.Th), trabecular
number (Tb.N), trabecular spacing (Tb.Sp), cortical area (Ct.A) and
cortical thickness (Ct.Th), which provide an assessment of local bone
quality (Bouxsein et al., 2010). For example, see (Johnston et al., 2007)
who investigated the eﬀect of a combined Teriparatide and Alendronate
treatment with this animal model.
Although these are rarely explicitly stated, this model relies on a
number of assumptions:
1 The ovariectomy produces in mice a systemic osteopenia similar to
age-related osteoporosis in humans;
2 The sham surgery is required to normalise for the systemic eﬀect of
surgery;
3 The proximal tibia cancellous bone and the measurement of the
properties of the cortical at a thin portion of the mid-shaft well re-
present global skeletal changes (negligible spatial gradient).
4 The changes at four weeks are representative of the long-term re-
sponse (negligible temporal gradient after the time point);
The above-mentioned analyses can also be performed longitudinally
by using an in vivo microCT imaging (Dall’Ara et al., 2016) where each
mouse would act as its own control, instead of the standard cross-sec-
tional design. In a ﬁrst study (Lu et al., 2015) we explored surface-to-
surface distance as a measure of bone remodelling between two con-
secutive time points, subsequent to proper image segmentation and
Boolean operations, an approach similar to that used by Ralph Müller’s
group at ETH Zurich to investigate the bone remodelling of mouse
caudal vertebrae (Christen and Muller, 2017; Schulte et al., 2011).
While the method was found very accurate by using repeated scans,
when applied to longitudinal data it highlighted that even after 14
weeks of age mouse tibiae continue to grow, and even if the linear
growth per week is small, in the order of a few hundred micrometres, it
biases heavily the bone remodelling quantiﬁcation, making diﬃcult to
separate changes due to growth from those due to bone remodelling. To
compensate for this, a new approach was adopted (Lu et al., 2016). The
3D images obtained at diﬀerent time-points were all aligned to the one
generated at the ﬁrst time-point (baseline) using rigid registration. In
each image the tibia was segmented by thresholding and its length
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calculated. The analyses included only the 80% of the bone below the
proximal growth plate, which was subdivided in ten equally spaced
sections, which were further subdivided into four anatomical oriented
(medial, lateral, anterior, posterior) compartments (Fig. 1, top). Using
this anatomical partitioning, we evaluated the reproducibility of var-
ious measurements, ﬁnding that the total Bone Mineral Content (BMC)
obtained by the necessary densitometric calibration was more re-
producible than other morphometric indicators, such BV/TV. A simple
power calculation showed that by using a longitudinal approach
enabled by in vivo imaging and the more reproducible BMC as metric of
bone adaptation, we could reduce of 63% the number of animals re-
quired in each group to achieve the same statistical power, with respect
to the traditional cross-sectional study described above (see Table1).
This reduction of the required animals for each group should be added
to the several animals that do not need to be sacriﬁced at each time
point. For example, if we are interested in measuring the bone changes
at six diﬀerent time points between two groups of 10 mice, with a
standard cross section study we would need 120 mice. With a long-
itudinal approach we would just need 8 mice.
Nevertheless, one potential concern for the longitudinal assessment
is that the X-ray ionising radiation that the repeated microCT scans
involve (approximately 500mGy per scan) might aﬀect the bone re-
modelling process, altering the very same biological mechanism we
want to observe. In small group of mice (N=5 per group) treated with
parathyroid hormone (PTH) or with vehicle, the right leg was scanned 8
times in vivo (once per week between weeks 14 and 22 of age, excluding
week 15 that was skipped) and at week 24 both right (irradiated) and
left (not irradiated) tibiae were scanned ex vivo. The diﬀerences be-
tween the total BMC of tibiae were between 3.7% and 8.0% (diﬀerence
for control group: 5.8 ± 1.9%, diﬀerence for treated group
5.1 ± 0.9%) (Lu et al., 2017). This diﬀerence was slightly larger than
that found between left and right tibiae of 10 control mice of the same
age (22 weeks) that were not irradiated (2.0 ± 1.3%, range: 0.3% to
3.7%). Therefore, as caution principle, we recently revised the long-
itudinal protocol to perform the scans every two weeks instead than
weekly and to half the scanning time which leads to a reduction of the
nominal ionising radiation dose from 513mGy to 256mGy per scan.
This reduction in scanning time was not associated with signiﬁcant
Fig. 1. Top: workﬂow to assess morphometric, densitometric and mechanical properties of the mouse tibia over time from longitudinal microCT images. The
longitudinal microCT data are used to evaluate the change in total bone mineral content (Tot BMC) over time with respect to baseline. Similarly the normalised
changes in bone mineral content (BMC) or other morphometric and densitometric properties are computed in 40 regions of the tibia by dividing it into ten
longitudinal sections and by dividng each section in four quadrants. Bottom: each microCT image can then be converted into a micro ﬁnite element (microFE) model
in order to estimate the changes in mechanical properties over time. For more details about the workﬂow please refer to (Lu et al., 2017).
Table 1
Theoretical sample size reduction (with 95% conﬁdence interval, CI) if data
from the longitudinal study are analysed by accounting for baseline measure-
ments or if they are analysed as standard cross-sectional study. The data are
reported for morphometric and densitometric parameters: Bone Volume
Fraction (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N),
cortical thickness (Ct.Th), total trabecular bone mineral content (Tb.BMC), total
cortical bone mineral content (Ct.BMC) and total bone mineral content
(Tot.BMC). The intra-class correlation (ICC) is also reported for each variable.
Variable ICC point
estimate
Theoretical sample
size reduction
(95% CI)
Standard Morphometric
parameters
BV/TV 0.59 34% (20% to 53%)
Tb.Th 0.13 13% (6% to 28%)
Ct.Th 0.64 28% (18% to 41%)
Tb.N 0.27 7% (2% to 18%)
BMC
parameters
Tb.BMC 0.71 51% (35% to 68%)
Ct.BMC 0.87 63% (54% to 71%)
Tot.BMC 0.87 63% (54% to 71%)
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diﬀerences in the estimated densitometric and mechanical properties of
the tibia (Oliviero et al., 2017).
The new method described here opened additional possibilities,
beyond the reduction of animal experimentation. A ﬁrst important
beneﬁt is that for the ﬁrst time it was possible to observe the eﬀect of an
intervention over a large anatomical site (the whole tibia), and across
time. We used this to explore how the injection of PTH would manifest
in space and time, with respect to WT mice without any intervention
(Lu et al., 2017). Indeed, the study found that the anabolic eﬀect of PTH
follows a speciﬁc spatial-temporal pattern, conﬁrming that spatial and
temporal gradients are not negligible.
Furthermore, the longitudinal scanning of the whole mouse tibia
allows to use mouse-speciﬁc computer modelling for the non-invasive
prediction of the bone strength, a much more informative quantity to
investigate the eﬀect of an intervention on the mechanical competence
of the skeleton. This application is explored in detail in the following
section.
4. Predicting bone strength non-invasively in mice
While animal models are useful for the prediction of eﬀect of novel
interventions on the density, microstructure and mechanical compe-
tence of the bone tissue, the diﬀerences in anatomy, physiology and
kinematics make it impossible to have a preclinical counterpart of the
clinical estimation of the risk of fracture. However, the bone mechan-
ical competence, an endpoint in the assessment of interventions which
is much more clinically relevant than standard densitometric and
morphometric measurements, should be measured or estimated when
possible.
As described above, from longitudinal microCT images we can
measure a large number of densitometric and morphometric parameters
that can be aﬀected by ageing, diseases and/or interventions. In most
cases it is hard to quantify the eﬃcacy of the interventions from this
multi-dimensional dataset: it is hard to assess how good is a treatment
that improves one of the morphometric parameters or only the bone
density in a small region of the considered bone. In this context the
measurement or estimation of a few mechanical parameters can provide
a much easier interpretation of the eﬀect of interventions, which target
an improvement of the bone mechanical competence. These parameters
include for the example the load required to induce a fracture (failure
load or bone strength), the load required to start permanent deforma-
tion in the bone (yield load), the bone stiﬀness and the energy required
to induce a fracture in the bone.
The mechanical properties of mice bones can be measured in the
laboratory through standard mechanical testing (Schriefer et al., 2005).
However, due to the complex shape and the small size of these ex vivo
analyses are aﬀected by experimental errors (Wallace et al., 2014) or
are limited to loading conditions, which are less physiologically re-
levant (e.g. three-point bending test). Moreover, the estimation of yield
or failure loads require destructive mechanical tests and can be there-
fore used only in standard cross-sectional studies, which require large
number of animals and resources.
Similarly, to subject-speciﬁc QCT-based approaches developed for
clinical applications, microCT-based ﬁnite element models (microFE)
can be used to non-invasively estimate the bone mechanical properties
longitudinally (Borg et al., 2018; Isaksson et al., 2009; Javaheri et al.,
2018; Lambers et al., 2012; Liu et al., 2012; Lu et al., 2012; Lynch et al.,
2010; Tiwari et al., 2018; Tiwari and Prasad, 2017; Ulrich et al., 1997,
1998; Wernle et al., 2010). The workﬂow to create a microFE model
from the medical image is similar to that developed for clinical CT
based ﬁnite elements for humans (Fig. 1, bottom). The bone voxels of
the rigidly registered microCT images of the mouse tibia collected in
vivo at the diﬀerent time points are separated from the background and
then converted into hexahedral ﬁnite elements. This in silico approach
allows us to simulate diﬀerent types of loading, the simplest and most
important for the tibia being uniaxial compression.
Unfortunately, conversely to the clinical counterpart, the validation
of the predictions of microFE outputs is limited to a few studies. While
microFE models have been found to well estimate structural stiﬀness
and strength of trabecular bone specimens (Schwiedrzik et al., 2016;
Wolfram et al., 2010) and to well estimate local displacement under
compression for trabecular bone (Chen et al., 2017) and vertebral
bodies (Costa et al., 2017), little has been done to validate models of the
mouse tibia. A few studies have found good agreement between the
predicted local strains in a region of the external surface of the mouse
tibia and experimental measurements performed with strain gauges
(Patel et al., 2014; Razi et al., 2015b) or digital image correlation
(Carriero et al., 2014; Pereira et al., 2015). However, the accuracy of
the predictions of internal strains or of the structural mechanical
properties of the tibia was never challenged. In a recent study per-
formed in our group (unpublished data) we combined mechanical
testing, microCT imaging, digital volume correlation and computa-
tional modelling to evaluate the ability of microFE models of the mouse
tibia to predicting local and structural properties (Oliviero et al., 2018).
The results of this pilot study (mechanical tests performed on six tibiae)
showed good predictions of local displacements when compared to
digital volume correlation measurements (coeﬃcient of determination
of the linear regressions between predicted and measured displace-
ments greater than 82%, intercepts close to 0 and slopes in the range:
0.69–0.95), an image processing technique that measures of the full
deformation ﬁeld given two microCT images of an undeformed and
deformed bone (Dall’Ara et al., 2014). Furthermore, both structural
bone stiﬀness (diﬀerence between predicted and measured stiﬀness
equal to 14 ± 11%) and bone strength (diﬀerence between predicted
and measured stiﬀness equal to 9 ± 9%) were well predicted.
By using these validated microFE models applied to longitudinal
microCT images we have estimated the eﬀect of an anabolic treatment
(parathyroid hormone, PTH1-34, base for the FDA approved drug
against osteoporosis Teriparatide) on the bone mechanical competence
of female C57BL/6 mice. In particular, we have shown that the tibia
stiﬀness and strength normalized by baseline measurements (week 14
of age) were signiﬁcantly higher after two weeks of treatment (treat-
ment started at week 18 of age) compared to the control group (Lu
et al., 2017).
5. The future: using models to translate from mouse to human
For the particular application addressed in this paper we have de-
scribed two methodologies that allow respectively in humans and in
mice to quantify non-invasively the changes in bone mass distribution
in a given bone, and the relative changes in mechanical strength (and
thus of the risk of fracture) under representative loading conditions.
It might be interesting to speculate how these two technologies
could be combined. As a guiding example we will imagine a study
aimed to establish if the combination of PTH and physical therapy is
more eﬀective than PTH alone in reducing the risk of bone fracture
(Gardinier et al., 2015).
First, we would observe longitudinally the changes in bone mass
distribution in the tibia, with and without superposition of some
loading regime (say for example a vibration from the ground in
standing position). Longitudinal in vivo microCT would give us the
evolution of bone mass distribution over time, and animal-speciﬁc ﬁnite
element models would give us an estimate of the actual biomechanical
stimulus delivered in each point of that mouse’s tibia under the vibra-
tion exercise, so to build a clear correlation between the dose of PTH
injected, the intensity of the biomechanical stimulus, the anatomical
location, and bone adaptation response over time.
A second experiment would be done on osteoporosis patients, under
very similar conditions. We would use clinical CT to follow-up long-
itudinally changes in the bone mass distribution in the tibia but also in
the femur. We would build patient-speciﬁc ﬁnite element models to
calculate the actual biomechanical stimulus delivered in each point of
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that patient’s tibia by the vibration exercise.
As a ﬁrst step we would use the matching data at the tibia to build a
“scaling function” that tell us how the bone remodelling response ob-
served in the mouse for a given normalised dose of PTH and for a given
normalised level of biomechanical stimulus would correlate with that
observed in the human under the same normalised conditions. We
would then use this scaling function to predict the remodelling in the
human femur, using the mouse response in the tibia and the actual
normalised level of biomechanical stimulus in the femur predicted by
the patient-speciﬁc model. We would then validate this mouse-human
scaling model by comparing the predicted bone remodelling with that
observed in human in the femur form longitudinal clinical CT.
Assuming the predictive accuracy is suﬃciently good, we could now
test only in the mouse a diﬀerent dose or loading regime, or another
anabolic composition, and use the scaling model to predict how such
regime would change the bone mass distribution in the femur of the
cohort of patients with the initial data of those enrolled in the previous
study. Then we would use the CT2S technology to estimate how in that
cohort such changes in femoral bone mass would reduce the actual risk
of fracture at the hip.
All this would of course not replace the clinical trial, but we would
go the clinical trial with much more conﬁdence on the eﬃcacy of our
new treatment of what we can possibly achieve today with the current
animal experimentation approaches.
6. Discussion
In this paper we propose one possible scenario for the use of mod-
elling and simulation to reduce, reﬁne and replace animal experi-
mentation, and to improve the ability of animal experiments to predict
the outcome in humans. Of course, there are other more radical sce-
narios: for example, to use the animal experiments simply to inform the
inputs of in silico clinical trial population model, where a virtual po-
pulation is “virtually treated” with a new drug, which eﬀect is modelled
from experiments on mice. An even more radical approach would be to
skip animal experimentation altogether and inform such in silico clin-
ical trial population model with the results of experiments done in vitro,
on cell cultures. All these scenarios are plausible, and in fact in at least
one case, the regulators have already accepted in silico testing as a full
replacement of animal experiments (Man et al., 2014). The approach
we proposed here is somehow incremental with respect to the current
methods based on animal experimentation, and as such they may be
more rapidly adopted.
A fundamental assumption in such scenario is that a “scaling func-
tion” exist to quantitively translate observations made on mice to hu-
mans. Of course, case by case the existence of such function must be
demonstrated. Where no such function could be found, this would cast
serious doubts on the usefulness of that animal experiment to predict
the response in humans; in such case, modelling and simulation could
still be useful, this time to replace entirely animal experimentation.
7. Conclusions
In this manuscript we described an initial exploration where a set of
VPH technologies, originally developed to predict the risk of femoral
strength and hip fracture in osteoporotic patients, were adapted to as-
sess the eﬃcacy of bone drugs pre-clinically on mice. We also specu-
lated about a possible approach where animal-speciﬁc and patient-
speciﬁc models could be used to better translate the observation made
on animal models into predictions of response in humans.
We are conﬁdent that in vivo imaging and subject-speciﬁc modelling
technologies like the ones described here can not only reduce, reﬁne,
and in some cases even partially replace animal experimentation, but
also provide a much more rigorous reasoning framework through which
to interpret clinically the results of animal experiments.
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